Aug 24, 20242024/Q22.323B / 2.541B--
--2024/Q12.049B / 2.208B--
--2023/Q42.103B / 2.709B--
--2021/Q11.764B / 1.589B--
--2020/Q42.185B / 1.519B--
CN Stock MarketDetailed Quotes
600535 Tasly Pharmaceutical Group
- 15.07
- +0.43+2.94%
Market Closed Dec 12 15:00 CST
22.51BMarket Cap25.54P/E (TTM)
15.13High14.59Low229.20KlotVolume14.65Open14.64Pre Close342.67MTurnover1.53%Turnover Ratio21.02P/E (Static)1.49BShares17.4452wk High1.84P/B22.51BFloat Cap11.9152wk Low16.10Limit Up1.49BShs Float38.06Historical High13.18Limit Down3.69%Amplitude-3.05Historical Low0.66Dividend TTM14.95Avg Price87.57KlotAsk4.38%Div YieldTTM100Lot Size138.49KlotBid
Tasly Pharmaceutical Group Key Stats
Tasly Pharmaceutical Group Q3 2024 Earnings Date
Currency：CNYOct 26, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 2.09B | -- |
-4.06% | |||
| EPS | 0.21 | 0.12 | -0.09 |
| Miss Est. | -4.55% | -45.45% | -42.86% |
Analyst Rating
Dec 12, 2024
Tasly Pharmaceutical Group Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Tasly Pharmaceutical Group Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
